Critical review of controversial issues in the management of advanced pediatric liver tumors
Authors:
- Abha A. GuptaAGAbha A. Gupta
- Ansely WongAWAnsely Wong
- 1 December 2010
- journal article
- review article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 56 (7) , 1013-1018
Abstract
Hepatocellular carcinoma (HCC) and hepatoblastoma (HB) are the most common primary tumors of liver in children. The management of patients with locally advanced, unresectable disease or those with extra‐hepatic distant metastases provides substantial challenges to pediatric oncologists, hepatologists, and surgeons. Herein, we critically debate the two sides of three specific controversies: (1) the role of chemotherapy in the treatment of advanced pediatric HCC; (2) the indications for liver transplantation in children with HCC, specifically, the appropriateness of using adult Milan criteria; and (3) the role of liver trasplantation in children with unresectable HB that present with metastatic disease. Pediatr Blood Cancer 2011;56:1013–1018.Keywords
This publication has 65 references indexed in Scilit:
- Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trialEuropean Journal of Cancer, 2009
- Phase I Trial and Pharmacokinetic Study of Ixabepilone Administered Daily for 5 Days in Children and Adolescents With Refractory Solid TumorsJournal of Clinical Oncology, 2009
- Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies #Hepatology, 2009
- A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumorsCancer, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- The Role of Liver Transplantation in the Management of Paediatric Liver TumoursThe Annals of The Royal College of Surgeons of England, 2007
- Risk-adapted treatment for childhood hepatoblastomaEuropean Journal of Cancer, 2004
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescenceThe Journal of Pediatrics, 2000
- Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastomaEuropean Journal of Cancer, 1997